ORKA
Oruka Therapeutics, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.98B
P/E Ratio
—
EPS
$-1.96
Beta
—
52W High
$91.00
52W Low
$8.91
50-Day MA
$50.44
200-Day MA
$30.91
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. is a biotechnology company.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-121.97M |
| Operating Margin | 0.00% |
| Return on Equity | -24.70% |
| Return on Assets | -17.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $9.63 |
| Price-to-Book | 7.99 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $59.86M |
| Float | $37.72M |
| % Insiders | 1.41% |
| % Institutions | 92.41% |
Historical Volatility
HV 10-Day
92.96%
HV 20-Day
82.09%
HV 30-Day
79.25%
HV 60-Day
80.32%
HV Rank
71.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($142.17 target)
2
Strong Buy11
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026